Europe Extends Locally Produced Monkeypox Vaccine Authorization

In Travel Vaccine News by Travel Vaccine

Denmark-based Bavarian Nordic A/S recently announced that the European Commission (EC) extended the marketing authorization for the Imvanex® smallpox vaccine to include protection from monkeypox and disease caused by the vaccinia virus. 
The new EC approval is valid in all European Union Member States as well as in Iceland, Liechtenstein, and Norway.

Read More